Drug Interactions Database

3916 interactions from BNF 85 - Check your medicines

Source: BNF 85
Severity: All 6278 Severe 944 Moderate 1418 Unknown 3916
apalutamide antiepileptics

decreases exposure

Unknown Theoretical
apalutamide antihistamines,non-sedating

decreases exposure

Unknown Study
apalutamide atorvastatin

decreases exposure

Unknown Study
apalutamide benzodiazepines

decreases exposure

Unknown Study
apalutamide beta

decreases exposure

Unknown Study
apalutamide colchicine

decreases exposure

Unknown Study
apalutamide coumarins

decreases exposure

Unknown Study
apalutamide dabigatran

decreases exposure

Unknown Study
apalutamide diazepam

decreases exposure

Unknown Study
apalutamide digoxin

decreases exposure

Unknown Study
apalutamide fexofenadine

decreases exposure

Unknown Study
apalutamide lansoprazole

decreases exposure

Unknown Study
apalutamide levothyroxine

decreases exposure

Unknown Theoretical
apalutamide methotrexate

decreases exposure

Unknown Study
apalutamide moclobemide

decreases exposure

Unknown Study
apalutamide omeprazole

decreases exposure

Unknown Study
apalutamide protonpumpinhibitors

decreases exposure

Unknown Study
apalutamide rabeprazole

decreases exposure

Unknown Study
apalutamide rosuvastatin

decreases exposure

Unknown Study
apalutamide simvastatin

decreases exposure

Unknown Study
apalutamide statins

decreases exposure

Unknown Study
apalutamide thrombininhibitors

decreases exposure

Unknown Study
apalutamide thyroidhormones

decreases exposure

Unknown Theoretical
apalutamide ulipristal

decreases efficacy

Unknown Theoretical
apalutamide valproate

decreases exposure

Unknown Theoretical
aprepitant antiarrhythmics

increases exposure

Unknown Theoretical
aprepitant antifungals,azoles

increases exposure

Unknown Theoretical
aprepitant coumarins

decreases anticoagulant effect

Unknown Study
aprepitant dronedarone

increases exposure

Unknown Theoretical
aprepitant isavuconazole

increases exposure

Unknown Theoretical
asciminib alfentanil

increases exposure

Unknown Theoretical
asciminib coumarins

increases exposure

Unknown Theoretical
asciminib dabigatran

increases exposure

Unknown Theoretical
asciminib digoxin

increases exposure

Unknown Theoretical
asciminib ergotamine

increases exposure

Unknown Theoretical
asciminib everolimus

increases exposure

Unknown Theoretical
asciminib opioids

increases exposure

Unknown Theoretical
asciminib sirolimus

increases exposure

Unknown Theoretical
asciminib temsirolimus

increases exposure

Unknown Theoretical
asciminib thrombininhibitors

increases exposure

Unknown Theoretical
asciminib warfarin

increases exposure

Unknown Theoretical
ascorbicacid deferiprone

increases risk of cardiovascularadverseeffects

Unknown Theoretical
ascorbicacid desferrioxamine

increases risk of cardiovascularadverseeffects

Unknown Theoretical
ascorbicacid ironchelators

increases risk of cardiovascularadverseeffects

Unknown Theoretical
asparaginase imatinib

increases risk of hepatotoxicity

Unknown Theoretical
asparaginase methotrexate

affects efficacy

Unknown Anecdotal
asparaginase vincaalkaloids

increases risk of neurotoxicity

Unknown Anecdotal
asparaginase vincristine

increases risk of neurotoxicity

Unknown Anecdotal
aspirin alendronate

increases risk of gastrointestinalirritation

Unknown Study
aspirin bisphosphonates

increases risk of gastrointestinalirritation

Unknown Study
Prev 1 ... 4 5 6 7 8 ... 79 Next
3916 interactions
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.